Indian drugmaker Aurobindo Pharma reported a lower first-quarter profit on Monday, as expenses grew faster than revenue - stung by weak prices in the key U.S. market.

Aurobindo Pharma reports a 10.2% YoY drop in Q1 FY26 PAT, citing API sales and US market revenue decline. The company's ...

Mumbai :Aurobindo Pharma Limited on Monday reported a 10.2 per cent year-on-year (YoY) drop in consolidated net profit to Rs ...

Aurobindo Pharma on Monday reported a 10 per cent decline in its consolidated net profit to Rs 824 crore for the June quarter ...

Aurobindo Pharma reported a 10.2% YoY decline in Q1 net profit to ₹824.2 crore, missing CNBC-TV18 estimates. Revenue rose 4%, ...

Shree Cements, Aurobindo Pharma, DLF, Siemens Energy, Bosch, and Marico among 192 companies to release earnings report today.

Aurobindo Pharma Ltd. announced on Monday an interim dividend of Rs 4 per equity share with a face value of Re 1 for the ...

Aurobindo Pharma's revenue increased by 4% year-on-year for the three months ended June, reaching Rs 7,868 crore.

Aurobindo Pharma reports 10% decline in Q1 net profit to Rs 824 crore due to lower US sales. Revenue rises to Rs 7,868 crore.

Key stocks to watch on August 5 include DLF, Aurobindo Pharma, LTIMindtree, Sona BLW, Paytm, and more, following key earnings ...

Aurobindo Pharma reports a 10% decline in consolidated net profit to Rs 824 crore for the June quarter, due to dwindling ...